Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
11.05
-0.24 (-2.13%)
Mar 20, 2026, 3:00 PM CST

SHA:603439 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4,4725,2057,7385,6376,4838,252
Market Cap Growth
-14.60%-32.74%37.27%-13.05%-21.44%-
Enterprise Value
5,0225,4457,4215,3426,1617,991
Last Close Price
11.0512.6318.0813.0615.0318.98
PE Ratio
27.6618.9926.4428.0142.5887.84
Forward PE
-13.8126.53---
PS Ratio
2.582.434.734.696.9113.09
PB Ratio
2.893.264.534.556.288.40
P/TBV Ratio
6.156.8811.375.816.418.51
P/FCF Ratio
119.9084.1246.0732.5150.27715.14
P/OCF Ratio
65.6048.6127.9719.2241.82130.48
EV/Sales Ratio
2.892.544.544.456.5612.68
EV/EBITDA Ratio
17.8713.5424.4424.2437.7870.73
EV/EBIT Ratio
28.2016.5827.7726.1140.5676.20
EV/FCF Ratio
134.6388.0044.1830.8147.77692.48
Debt / Equity Ratio
0.520.380.330.170.190.20
Debt / EBITDA Ratio
2.871.501.830.931.231.77
Debt / FCF Ratio
21.659.813.301.191.5517.33
Net Debt / Equity Ratio
0.310.07-0.04-0.34-0.43-0.39
Net Debt / EBITDA Ratio
1.720.27-0.22-1.93-2.71-3.36
Net Debt / FCF Ratio
12.931.74-0.40-2.45-3.43-32.93
Asset Turnover
0.590.700.690.750.710.63
Inventory Turnover
1.672.633.203.644.074.14
Quick Ratio
1.061.161.561.942.793.30
Current Ratio
1.451.461.782.143.053.49
Return on Equity (ROE)
9.67%16.94%20.01%16.91%14.76%11.51%
Return on Assets (ROA)
3.77%6.71%7.05%7.94%7.13%6.59%
Return on Invested Capital (ROIC)
7.85%16.91%19.22%25.16%21.45%14.78%
Return on Capital Employed (ROCE)
9.50%16.80%12.80%16.10%14.50%10.50%
Earnings Yield
3.59%5.27%3.78%3.57%2.35%1.14%
FCF Yield
0.83%1.19%2.17%3.08%1.99%0.14%
Dividend Yield
3.01%2.69%1.11%0.77%-1.32%
Payout Ratio
100.07%37.97%17.40%4.43%72.37%-
Buyback Yield / Dilution
3.85%0.79%-0.36%0.19%-5.14%-5.90%
Total Shareholder Return
6.79%3.48%0.75%0.96%-5.14%-4.58%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.